Posts tagged “Biotech & Life Science”
Another life science services firm in the Triangle, PRA International, may follow in the footsteps of a bigger rival - Quintiles - by offering stock in order to raise capital. Just two years ago, PRA was at the center of takeover rumors in the range of $1 billion.
Built around 30 climate-controlled "environments" contained in all-glass greenhouses, the new 136,000 square foot facility had been under construction for nearly two years.
New SAS software cuts "big data" analysis from days, even hours, down to seconds. Learn why SAS sees big opportunity in the health care space.
Fresh off an IPO that produced $1 billion for investors and the company, Quintiles on Wednesday announced a drug development deal in which it will work with Germany-based Merck Serono. But this contract is much different from others in which Quintiles shared some of the financial risk for new drug development. WRALTechWire Insiders get the story beyond the press release.
Quintiles completes its IPO selling 27.2 million shares, including the overallotment sold by investors who took stakes in Quintiles when it was private. Read just how much they stand to gain from the additional sale.
From a tobacco town to a city of medicine to a technology hub - that's the saga of Durham. Beginning next week, WRALTechWire will launch a multi-day, in-depth report titled "The New Bull City" that will tell the stories behind Durham's rebirth and what's coming next.
Cemrpa is a long way yet from proving its new antibiotic compound will be an effective, FDA-approved drug, but the compound has already delivered the company a $10 million payday with millions more possibly to come. WRALTechWire Insiders get the details.
The introductory 50-percent off deal to become an Insider at WRALTechWire expires on May 16. Sign up today for accesses to in-depth exclusive news and much more - such as up to $900 in savings on tech-related offers from our partners.
Elan will receive 21 percent of the royalties earned by Theravance from GlaxoSmithKline on the four respiratory medicines, and 20 percent of that income stream will be paid to Elan shareholders as a dividend.
Scientific research has revealed many things but science is still keeping some secrets from David Murdock. The billionaire businessman founded and funded the David H. Murdock Research Institute to search for answers. And now he's putting up $50 million more in his continuing quest.